Literature DB >> 15919372

The lymphoid chemokine CCL21 costimulates naive T cell expansion and Th1 polarization of non-regulatory CD4+ T cells.

Kenneth Flanagan1, Dorota Moroziewicz, Heesun Kwak, Heidi Hörig, Howard L Kaufman.   

Abstract

CCL21 (SLC/6Ckine) is constitutively expressed by secondary lymphoid tissue and attracts CCR7-expressing mature dendritic cells and naive T cells. Recent studies demonstrated that intra-tumoral delivery of CCL21 induces tumor regression in a T cell dependent manner. CCL21 is known to mediate T cell trafficking but little is known about its function as a costimulatory molecule. Herein, we demonstrate that CCL21 costimulates expansion of CD4+ and CD8+ T cells and induces Th1 polarization. These effects were specific for naive T cells, and we show that CD4+CD25+ regulatory T cells were hyporesponsive to CCL21 induced migration, and unresponsive to CCL21 costimulation. These unique functions of CCL21 to both attract naive T cells as well as costimulate their proliferation and differentiation, suggests that CCL21 is a pivotal molecule for priming T cell responses and has therapeutic implications for local delivery of CCL21. The coordinated effects of CCL21 on T cell migration and activation may also represent a more comprehensive paradigm for the activity of other chemokines as well.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15919372     DOI: 10.1016/j.cellimm.2004.12.006

Source DB:  PubMed          Journal:  Cell Immunol        ISSN: 0008-8749            Impact factor:   4.868


  33 in total

1.  Microbial induction of B and T cell areas in rabbit appendix.

Authors:  Nicholas B Hanson; Dennis K Lanning
Journal:  Dev Comp Immunol       Date:  2008-02-25       Impact factor: 3.636

2.  A DNA-based cancer vaccine enhances lymphocyte cross talk by engaging the NKG2D receptor.

Authors:  He Zhou; Yunping Luo; Charles D Kaplan; Jörg A Krüger; Sung-Hyung Lee; Rong Xiang; Ralph A Reisfeld
Journal:  Blood       Date:  2005-12-20       Impact factor: 22.113

3.  CCL21 Chemokine Therapy for Lung Cancer.

Authors:  Sherven Sharma; Li Zhu; Minu K Srivastava; Marni Harris-White; Min Huang; Jay M Lee; Fran Rosen; Gina Lee; Gerald Wang; Valerie Kickhoefer; Leonard H Rome; Felicita Baratelli; Maie St John; Karen Reckamp; Seok Chul-Yang; Sven Hillinger; Robert Strieter; Steven Dubinett
Journal:  Int Trends Immun       Date:  2013-01

4.  Chemokine receptor CCR7 regulates the intestinal TH1/TH17/Treg balance during Crohn's-like murine ileitis.

Authors:  Eóin N McNamee; Joanne C Masterson; Marisol Veny; Colm B Collins; Paul Jedlicka; Fergus R Byrne; Gordon Y Ng; Jesús Rivera-Nieves
Journal:  J Leukoc Biol       Date:  2015-01-30       Impact factor: 4.962

Review 5.  Compartmentalization of dendritic cell and T-cell interactions in the lymph node: Anatomy of T-cell fate decisions.

Authors:  Beatriz León; Frances E Lund
Journal:  Immunol Rev       Date:  2019-05       Impact factor: 12.988

6.  Substrate-bound CCL21 and ICAM1 combined with soluble IL-6 collectively augment the expansion of antigen-specific murine CD4+ T cells.

Authors:  Shimrit Adutler-Lieber; Irina Zaretsky; Helena Sabany; Elena Kartvelishvily; Ofra Golani; Benjamin Geiger; Nir Friedman
Journal:  Blood Adv       Date:  2017-06-15

7.  Homeostatic chemokines CCL19 and CCL21 promote inflammation in human immunodeficiency virus-infected patients with ongoing viral replication.

Authors:  J K Damås; L Landrø; B Fevang; L Heggelund; G E Tjønnfjord; Y Fløisand; B Halvorsen; S S Frøland; P Aukrust
Journal:  Clin Exp Immunol       Date:  2009-09       Impact factor: 4.330

8.  Immunogenic profiling in mice of a HIV/AIDS vaccine candidate (MVA-B) expressing four HIV-1 antigens and potentiation by specific gene deletions.

Authors:  Juan García-Arriaza; José Luis Nájera; Carmen E Gómez; Carlos Oscar S Sorzano; Mariano Esteban
Journal:  PLoS One       Date:  2010-08-24       Impact factor: 3.240

Review 9.  Therapeutic Lymphoid Organogenesis in the Tumor Microenvironment.

Authors:  Aliyah M Weinstein; Walter J Storkus
Journal:  Adv Cancer Res       Date:  2015-05-05       Impact factor: 6.242

10.  CCL21 mediates CD4+ T-cell costimulation via a DOCK2/Rac-dependent pathway.

Authors:  Kathrin Gollmer; François Asperti-Boursin; Yoshihiko Tanaka; Klaus Okkenhaug; Bart Vanhaesebroeck; Jeffrey R Peterson; Yoshinori Fukui; Emmanuel Donnadieu; Jens V Stein
Journal:  Blood       Date:  2009-05-18       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.